153 related articles for article (PubMed ID: 19224499)
1. Peripheral blood concentrations of vascular endothelial growth factor and its soluble receptors (R1 and R2) in patients with adrenal cortex tumours treated by surgery.
Jurczyńska J; Stepień T; Lawnicka H; Stepień H; Krupiński R; Kołomecki K; Kuzdak K; Komorowski J
Endokrynol Pol; 2009; 60(1):9-13. PubMed ID: 19224499
[TBL] [Abstract][Full Text] [Related]
2. The usefulness of determining the serum concentrations of vascular endothelial growth factor (VEGF) and its soluble receptor type 2 (sVEGF-2) in the differential diagnosis of adrenal incidentalomas.
Foltyn W; Strzelczyk J; Marek B; Kajdaniuk D; Siemińska L; Rosiek V; Kos-Kudła B
Endokrynol Pol; 2012; 63(1):22-8. PubMed ID: 22378094
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of VEGF, MMP-2, MMP-3 and TIMP-2 serum level evaluation in patients with adrenal tumours.
Kolomecki K; Stepien H; Bartos M; Kuzdak K
Endocr Regul; 2001 Mar; 35(1):9-16. PubMed ID: 11308991
[TBL] [Abstract][Full Text] [Related]
4. Minimally invasive colon resection for malignant colonic conditions is associated with a transient early increase in plasma sVEGFR1 and a decrease in sVEGFR2 levels after surgery.
Shantha Kumara HM; Cabot JC; Hoffman A; Luchtefeld M; Kalady MF; Hyman N; Feingold D; Baxter R; Whelan RL
Surg Endosc; 2010 Feb; 24(2):283-9. PubMed ID: 19551437
[TBL] [Abstract][Full Text] [Related]
5. [Assessment of pro- and antiangiogenic factors blood serum concentrations in patients with hormonal inactive adrenal tumors].
Korzeniewska M; Kołomecki K; Stepień H; Naze M; Stepień T; Kuzdak K
Endokrynol Pol; 2005; 56(1):39-44. PubMed ID: 16335673
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor and basic fibroblast growth factor evaluation in blood serum of patients with hormonally active and inactive adrenal gland tumours.
Kołomecki K; Stepień H; Narebski JM
Cytobios; 2000; 101(396):55-64. PubMed ID: 10697745
[TBL] [Abstract][Full Text] [Related]
7. Minimally invasive colon resection is associated with a transient increase in plasma sVEGFR1 levels and a decrease in sVEGFR2 levels during the early postoperative period.
Shantha Kumara HM; Cabot JC; Hoffman A; Luchtefeld M; Kalady MF; Hyman N; Feingold D; Baxter R; Whelan RL
Surg Endosc; 2009 Apr; 23(4):694-9. PubMed ID: 19184203
[TBL] [Abstract][Full Text] [Related]
8. Soluble receptors for vascular endothelial growth factor (sVEGFR1/sVEGFR2) in infantile hemangioma.
Przewratil P; Sitkiewicz A; Andrzejewska E
Growth Factors; 2010 Dec; 28(6):417-25. PubMed ID: 20854187
[TBL] [Abstract][Full Text] [Related]
9. Serum concentrations of TNF α and its soluble receptors in patients with adrenal tumors treated by surgery.
Komorowski J; Jurczynska J; Stepien T; Kolomecki K; Kuzdak K; Stepien H
Int J Mol Sci; 2010 May; 11(6):2281-90. PubMed ID: 20640152
[TBL] [Abstract][Full Text] [Related]
10. Elevated plasma levels of tissue factor as a valuable diagnostic biomarker with relevant efficacy for prediction of breast cancer morbidity.
Zarychta E; Rhone P; Bielawski K; Rosc D; Szot K; Zdunska M; Ruszkowska-Ciastek B
J Physiol Pharmacol; 2018 Dec; 69(6):. PubMed ID: 30802214
[TBL] [Abstract][Full Text] [Related]
11. Clinical usefulness of assessing VEGF and soluble receptors sVEGFR-1 and sVEGFR-2 in women with breast cancer.
Thielemann A; Baszczuk A; Kopczyński Z; Kopczyński P; Grodecka-Gazdecka S
Ann Agric Environ Med; 2013; 20(2):293-7. PubMed ID: 23772579
[TBL] [Abstract][Full Text] [Related]
12. Analysis of circulating vascular endothelial growth factor and its soluble receptors in patients with different forms of chronic urticaria.
Jagodzinska J; Polaniak R; Birkner E; Kasperska-Zajac A
Biomed Res Int; 2015; 2015():578383. PubMed ID: 25756047
[TBL] [Abstract][Full Text] [Related]
13. Circulating vascular endothelial growth factor (VEGF) and its soluble receptors in patients with chronic lymphocytic leukemia.
Gora-Tybor J; Blonski JZ; Robak T
Eur Cytokine Netw; 2005; 16(1):41-6. PubMed ID: 15809205
[TBL] [Abstract][Full Text] [Related]
14. Perioperative sargramostim (recombinant human GM-CSF) induces an increase in the level of soluble VEGFR1 in colon cancer patients undergoing minimally invasive surgery.
Kirman I; Belizon A; Balik E; Feingold D; Arnell T; Horst P; Kumara S; Cekic V; Jain S; Nasar A; Whelan RL
Eur J Surg Oncol; 2007 Dec; 33(10):1169-76. PubMed ID: 17512160
[TBL] [Abstract][Full Text] [Related]
15. Circulating vascular endothelial growth factor and its soluble receptors in patients with liver cirrhosis: possible association with hepatic function impairment.
Jaroszewicz J; Januszkiewicz M; Flisiak R; Rogalska M; Kalinowska A; Wierzbicka I
Cytokine; 2008 Oct; 44(1):14-7. PubMed ID: 18656381
[TBL] [Abstract][Full Text] [Related]
16. Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes.
Hu Q; Dey AL; Yang Y; Shen Y; Jilani IB; Estey EH; Kantarjian HM; Giles FJ; Albitar M
Cancer; 2004 May; 100(9):1884-91. PubMed ID: 15112269
[TBL] [Abstract][Full Text] [Related]
17. Selected angiogenic factors in plasma of patients with lower limb symptomatic peripheral arterial disease: preliminary report.
Wieczór R; Gadomska G; Góralczyk B; Stankowska K; Budzyński J; Fabisiak J; Suppan K; Pulkowski G; Rość D
Int Angiol; 2015 Dec; 34(6):545-51. PubMed ID: 25394959
[TBL] [Abstract][Full Text] [Related]
18. Disruption of components of vascular endothelial growth factor angiogenic signalling system in metabolic syndrome. Findings from a study conducted in rural Bangladeshi women.
Jesmin S; Akter S; Rahman MM; Islam MM; Islam AM; Sultana SN; Mowa CN; Yamaguchi N; Okazaki O; Satoru K; Kimura S; Hiroe M; Mizutani T; Moroi M
Thromb Haemost; 2013 Apr; 109(4):696-705. PubMed ID: 23364276
[TBL] [Abstract][Full Text] [Related]
19. Ovarian hyperstimulation syndrome is correlated with a reduction of soluble VEGF receptor protein level and a higher amount of VEGF-A.
Pietrowski D; Szabo L; Sator M; Just A; Egarter C
Hum Reprod; 2012 Jan; 27(1):196-9. PubMed ID: 22016416
[TBL] [Abstract][Full Text] [Related]
20. Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.
Wierzbowska A; Robak T; Wrzesień-Kuś A; Krawczyńska A; Lech-Marańda E; Urbańska-Ryś H
Eur Cytokine Netw; 2003; 14(3):149-53. PubMed ID: 14656688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]